The company, which has its U.S. headquarters at the Spring House Innovation Park, expects to begin enrolling patients in its Phase 1 clinical trial during the first quarter of this year.
The company, which has its U.S. headquarters at the Spring House Innovation Park, expects to begin enrolling patients in its Phase 1 clinical trial during the first quarter of this year.
